[Survey of prevalence of hepatitis C in people aged 1-69 years in Henan Province, 2020]

Zhonghua Liu Xing Bing Xue Za Zhi. 2023 Jul 10;44(7):1114-1118. doi: 10.3760/cma.j.cn112338-20220815-00711.
[Article in Chinese]

Abstract

Objective: To understand the infection status and epidemiological characteristics of hepatitis C in people aged 1-69 years in Henan Province in 2020. Methods: The estimated sample size was 5 827. From August to December 2020, multistage sampling was used to select 8 counties (districts) in Henan, and two survey sites were selected in each county (district), and a questionnaire survey was conducted in local people aged 1-69 years, blood samples were collected from them for anti-HCV, HCV RNA and genotype detections. Results: A total of 5 165 people aged 1-69 years completed the questionnaire survey. Men accounted for 44.76% (2 312/5 165), women accounted for 55.24% (2 853/5 165). In the people aged 1-69 years, the overall prevalence rates of anti-HCV and HCV RNA were 0.69% (95%CI: 0.68%-0.70%) and 0.20% (95%CI: 0.19%-0.21%) respectively. The prevalence rates of anti-HCV and HCV RNA were 0.48% (95%CI: 0.46%-0.50%), 0.09% (95%CI: 0.08%-0.10%) in men and 0.86% (95%CI: 0.85%-0.87%), 0.30% (95%CI: 0.28%-0.32%) in women. The prevalence rates of anti-HCV and HCV RNA increased with age. The prevalence rates of anti-HCV and HCV RNA were 0.87% (95%CI: 0.86%-0.88%), 0.28% (95%CI: 0.26%-0.30%) in urban residents and 0.53% (95%CI: 0.51%-0.55%), 0.14% (95%CI: 0.13%-0.15%) in rural residents. The genotyping results of 10 HCV RNA positive samples ware genotype 1b (4/10), genotype 2 (3/10), genotype 1b/3 (1/10), genotype 1b/3/6 (1/10) and genotype 2/6 (1/10). Conclusions: The prevalence of hepatitis C was low in Henan in 2020. It is necessary to strengthen hepatitis C surveillance in people aged 40 years and above. The major HCV genotypes were 1b and 2, and mixed genotype infection existed.

目的: 了解2020年河南省1~69岁人群丙型肝炎(丙肝)流行状况和特征。 方法: 估计样本量为5 827人。采用多阶段抽样,于2020年8-12月在河南省抽取8个县(区),每个县(区)抽取2个调查点,对1~69岁的人群进行问卷调查,并采集静脉血液标本进行HCV抗体、核酸和基因型检测。 结果: 调查5 165人,其中男性占44.76%(2 312/5 165),女性占55.24%(2 853/5 165)。1~69岁的人群抗-HCV、HCV RNA调整阳性率分别为0.69%(95%CI:0.68%~0.70%)和0.20%(95%CI:0.19%~0.21%)。男性抗-HCV和HCV RNA调整阳性率分别为0.48%(95%CI:0.46%~0.50%)和0.09%(95%CI:0.08%~0.10%);女性为0.86%(95%CI:0.85%~0.87%)和0.30%(95%CI:0.28%~0.32%)。抗-HCV和HCV RNA阳性率均呈随年龄增长而增加的趋势。城市人群抗-HCV和HCV RNA调整阳性率分别为0.87%(95%CI:0.86%~0.88%)和0.28%(95%CI:0.26%~0.30%);农村为0.53%(95%CI:0.51%~0.55%)和0.14%(95%CI:0.13%~0.15%)。10人HCV RNA阳性样本的基因型分别为1b型(4/10)、2型(3/10)、1b/3型(1/10)、1b/3/6型(1/10)和2/6型(1/10)。 结论: 2020年河南省丙肝流行率较低,年龄≥40岁是开展丙肝监测工作的重点人群。HCV基因型以1b型和2型为主,存在混合基因型感染情况。.

Publication types

  • English Abstract

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Child
  • Child, Preschool
  • Coinfection*
  • Female
  • Genotype
  • Hepacivirus / genetics
  • Hepatitis C Antibodies / genetics
  • Hepatitis C* / epidemiology
  • Humans
  • Infant
  • Male
  • Middle Aged
  • Prevalence
  • RNA, Viral / genetics
  • Surveys and Questionnaires
  • Young Adult

Substances

  • Hepatitis C Antibodies
  • RNA, Viral